Primary sources · zero speculation
What the FDA is doing this year.
The peptide regulatory landscape in 2026 is in motion. We track it with public records, Federal Register notices, and transparent changelogs — no rumor, no speculation.
Tracker
2026 Peptide Reclassification Tracker
Every Category 2 and removed-from-list peptide: current status, proposed status, last FDA action, source documents. Updated as the Federal Register publishes.
View trackerFramework
How To Evaluate a Compounding Pharmacy
The 10-criterion framework we use to assess a 503A/503B compounder. Public-record data only — no affiliate relationships with any rated entity.
View frameworkNot medical advice
Nothing on this site recommends any peptide, vendor, or course of action. See our Medical Disclaimer.
Regulatory dispatches
FDA moves, summarized.
Federal Register notices and compounding updates delivered in plain English — only when something actually changes.